Use Code ELEVATE10 for 10% off any subscription. View Products

Weekly Elevate Watchlist 10/31/21

Weekly Elevate Watchlist 10/31/21

Hey everyone, Happy Halloween!! Hope you’re is having a great weekend. Going to get started on the Sunday Watchlist. Let’s get started with what to eye tomorrow. 

$ABVC, looks like their prepared for futures offerings of up to $50M. We may from time to time, in one or more offerings at prices and on terms that we will determine at the time of each offering, sell common stock, preferred stock, warrants, or a combination of these securities, or units, for an aggregate offering price of up to $50,000,000. that news was on friday and the stocked popped hard. heres the trend to eye if you want to eye it.
$TEVA. New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Time to Impending Relapse Compared to Placebo in Patients with Schizophrenia. news out this weekend. have a eye here in the am. Interesting read. Here’s some resistance areas to eye here tomorrow.
 
$ZSAN, On October 27, 2021, the Company submitted a briefing package to the U.S. Food and Drug Administration (the “FDA”) in advance of the Type C Written Response Only meeting request, previously granted by the FDA, to obtain feedback on the Company’s strategy for resubmitting the M207 (zolmitriptan transdermal microneedle system) 505(b)(2) New Drug Application, as previously disclosed in the Company’s current report on Form 8-K filed with the Securities and Exchange Commission on October 6, 2021. news on friday, nice pop here, eye the breaks of .73 and .765 tomorrow here.

Let’s talk stocks with news coming here in the next few weeks.

$OCGN, news coming tuesday, lots of rumors here. News should be out on friday. But im not so sure their getting approval. Saw insider selling, here’s a article as well saying they need more info. Great swing here, to much uncertainty. Stay nimble. 
$ETON, During the quarter, Azurity submitted responses to the FDA’s review questions which the FDA deemed to be an amendment to the application and resulted in the FDA extending the application’s PDUFA date to November 6, 2021. so the news will be next weekend. Here’s the chart to eye here. have a eye here in the coming days into that date.
$LQDA, Liquidia Announces FDA Acceptance of New Drug Application Resubmission for LIQ861 (treprostinil) Inhalation Powder, The FDA set a PDUFA goal date of November 7, 2021. liking the chart here, seeing a golden cross with the 50 and 200 SMA’s. 
 
$ACHR, newish stock. IPO was in sept. 18% shorted on the float. The shorts getting greedy here. Needs a rebound and soon. 
$OWLT, another one that is completely slaughtered, over 20% is shorted here on the float. looking for a double bottom or a bullish sign to see these shorts squeeze out. 
$NRDY, little pop here over the last trading session. want to eye this one based on the chart, seeing MACD converging, and seeing a curl on RSI. have a eye on this one over the next few weeks.
  1. others that are oversold and highly shorted. $MITO, $BLCM, $BBIG, $SHPI, $OCUL, $TIGR, $FCUV, $RFL.
  1. Here’s the highest shorted stocks in the markets.

Thanks for reading! What a week last week was. Killer profits made by the team. Elevate your trading and take it to the next level! Sign up at ElevateTrader.com Use Promo Code GHOST25 for 25% off all packages!

Share:

DISCLAIMER

The forum, blog, watchlist and chatrooms on the Site are comprised of customers and members (including, without limitation, moderators who are in the employ of Elevate Trader) posting content and information. All such information and content is for informational purposes only and does not constitute advice or a recommendation by Elevate Trader to enter into any securities transactions or engage in any of the financial strategies reflected on or suggested in forum, blog, watchlist and chatrooms (whether such data, content or information is posted by Elevate Trader or otherwise). Customers and members may write about securities in which they have a financial or other interest, and performance data reflecting other customer’s or member’s holdings may include information about securities not held by Elevate Trader or its directors, officers, shareholders, employees, agents or affiliates. As such, Elevate Trader is not responsible for the accuracy of data, content or information or any performance data in any forum, blog, watchlist and chatrooms; and the accuracy of data, content or information or any performance data are not guaranteed, may not be current and should not be relied upon. Nothing in any forum, blog, watchlist and chatrooms is intended as, nor should you rely on it as, investment advice provided by Elevate Trader or its directors, officers, shareholders, employees, agents or affiliates.

ELEVATE THE WAY YOU TRADE!

Try a trial – for less than a cup of coffee

Share: